Health Decisions, a full-service clinical research organization (CRO) specializing in high-efficiency adaptive methods, will be represented by CEO Dr. Michael Rosenberg at the DIA 4th Annual Clinical Forum October 11 -13 in Lisbon, Portugal. Dr. Rosenberg will address the Forum with a presentation titled “Adaptive Monitoring: Faster, Better e-Monitoring.” It will highlight the advantages and requirements of adopting innovative monitoring methods and technologies.
“An adaptive monitoring system builds on the same basic principles as adaptive design. But instead of interim reviews of patient data, adaptive monitoring deals with operational metrics on an iterative, day-to-day scale,” said Dr. Rosenberg. “With the ability to access constant flows of meaningful metrics in near-real time, study teams can respond more quickly—often preemptively—to emerging problems. As a result, drug and device developers benefit from better quality data, more efficient use of resources, and substantially shorter program cycles.”
“Adaptive Monitoring: Faster, Better e-Monitoring” will be presented during two Forum sessions at the Lisboa Congress Centre. The first session, Adaptive Design for Clinical Trials: Issues and Solutions, will take place Tuesday, October 12 from 9:00 to 10:30 AM WEST.
Dr. Rosenberg will repeat the presentation on Wednesday, October 13 from 9:00 to 10:30 AM WEST as part of the Monitoring Strategies for the Future session, chaired by Nermeen Y. Varawalla, CEO of ECCRO and featuring additional presentations from Kendle and Reliance Clinical Research Services. The DIA website provides additional information about the sessions, including a full program and registration information.
About Health Decisions
Health Decisions (healthdec.com) is a global clinical research organization (CRO) committed to helping drug and device companies achieve greater success. Our sponsors rely on us to help them prove the value of their pipelines both faster and with the smartest possible allocation of funds. Through Agile Clinical Development—a strategic combination of adaptive design and adaptive operations—Health Decisions optimizes every facet of clinical research from design protocol to the most detailed day-to-day management, so sponsors can make the most of competitive market opportunities.
Health Decisions is headquartered in Durham, NC, with over twenty years of experience helping sponsors achieve success in Phase I-IV trials across all major therapy areas. For more information, please visit the company's website at the link accompanying this press release.
DIA (diahome.org) is a neutral, global, professional, member-driven association of nearly 18,000 biotechnology, pharmaceutical, clinical or medical, academic and regulatory professionals, students and patient representatives. Through its international meetings, training courses, online learning and myriad networking opportunities, the DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit the website or call DIA in Europe +41 61 225 51 51